We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ING icon
901
ING
ING
$102B
$2K ﹤0.01%
200
– –
IPGP icon
902
IPG Photonics
IPGP
$3.71B
$2K ﹤0.01%
+11
New +$1.66K
KSS icon
903
Kohl's
KSS
$2.19B
$2K ﹤0.01%
44
– –
MOS icon
904
The Mosaic Company
MOS
$7.18B
$2K ﹤0.01%
91
– –
MTUM icon
905
iShares MSCI USA Momentum Factor ETF
MTUM
$26B
$2K ﹤0.01%
+13
New +$1.49K
NWL icon
906
Newell Brands
NWL
$2.62B
$2K ﹤0.01%
+108
New +$1.62K
OZK icon
907
Bank OZK
OZK
$5.69B
$2K ﹤0.01%
68
– –
QGEN icon
908
Qiagen
QGEN
$8.88B
$2K ﹤0.01%
48
– –
RGA icon
909
Reinsurance Group of America
RGA
$16.1B
$2K ﹤0.01%
+15
New +$2.25K
RHI icon
910
Robert Half
RHI
$4.25B
$2K ﹤0.01%
33
– –
RL icon
911
Ralph Lauren
RL
$23.6B
$2K ﹤0.01%
14
– –
TAK icon
912
Takeda Pharmaceutical
TAK
$55.6B
$2K ﹤0.01%
100
– –
TILE icon
913
Interface
TILE
$2.24B
$2K ﹤0.01%
126
-3,887
-97% -$61.2K
VEEV icon
914
Veeva Systems
VEEV
$39.2B
$2K ﹤0.01%
15
– –
VT icon
915
Vanguard Total World Stock ETF
VT
$81.4B
$2K ﹤0.01%
30
– –
GAP
916
The Gap Inc
GAP
$7.29B
$2K ﹤0.01%
112
– –
CDMO
917
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$2K ﹤0.01%
+300
New +$1.24K
AGR
918
DELISTED
Avangrid, Inc.
AGR
$2K ﹤0.01%
+30
New +$1.52K
SRCL
919
DELISTED
Stericycle Inc
SRCL
$2K ﹤0.01%
35
-150
-81% -$7.63K
RAD
920
DELISTED
Rite Aid Corporation
RAD
$2K ﹤0.01%
260
+10
+4% +$86
LHCG
921
DELISTED
LHC Group LLC
LHCG
$2K ﹤0.01%
+18
New +$2.03K
ZEN
922
DELISTED
ZENDESK INC
ZEN
$2K ﹤0.01%
22
– –
GCP
923
DELISTED
GCP Applied Technologies Inc.
GCP
$2K ﹤0.01%
94
– –
NPTN
924
DELISTED
NEOPHOTONICS CORP
NPTN
$2K ﹤0.01%
500
– –
WBT
925
DELISTED
Welbilt, Inc.
WBT
$2K ﹤0.01%
104
– –
35 36
37
38 39

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.